On Friday, shares of Apogee Therapeutics Inc (APGE) rose by about 6.3%, reaching a high of $44.64 and surpassing their 200-day moving average of $43.86. The last trade was reported at $44.48.
APGE’s performance over the past year shows a 52-week low of $26.20 per share and a 52-week high of $63.50.
